# Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

> **NCT00708084** · PHASE2 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 48 (actual)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** CL184
- **BIOLOGICAL:** HRIG

## Key facts

- **NCT ID:** NCT00708084
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708084, "Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00708084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*